Meloxicam and the Beers Criteria
Yes, meloxicam should be avoided in adults aged 65 and older according to the 2019 American Geriatrics Society Beers Criteria, as it is explicitly listed as a potentially inappropriate medication (PIM) in this population. 1
Classification and Recommendation
Meloxicam is categorized as a nonselective NSAID in the Beers Criteria and carries a strong recommendation to avoid use in older adults. 1 The evidence quality supporting this recommendation is rated as high, with a moderate quality of evidence for the strength of recommendation. 1
Rationale for Avoidance
The primary concerns driving this recommendation include:
Increased gastrointestinal bleeding risk: Oral NSAIDs, including meloxicam, significantly increase the risk of gastrointestinal bleeding and peptic ulcer disease in older adults, with approximately 2-4% experiencing gross bleeding. 1
Kidney injury: NSAIDs pose substantial risk for acute kidney injury in the elderly population. 1
Cardiovascular risks: These medications can worsen heart failure and increase blood pressure in older adults. 1
CNS effects: NSAIDs are associated with increased risk of delirium and other central nervous system adverse effects in geriatric patients. 1
High-Risk Situations
The recommendation to avoid meloxicam is particularly strong when older adults have:
- Heart failure (HFrEF) or reduced ejection fraction 1
- History of gastrointestinal ulcers or bleeding 1
- Concurrent use of anticoagulants, antiplatelet agents, or corticosteroids 1
- Chronic kidney disease 1
Clinical Context
While meloxicam is a preferential COX-2 inhibitor with a convenient once-daily dosing profile due to its 20-hour half-life 2, 3, this does not exempt it from the Beers Criteria restrictions. The 2019 update maintained meloxicam on the list of medications to avoid, with no dosage adjustment recommendations that would make it safer for elderly use. 1
Prevalence data demonstrates that PIMs remain commonly prescribed despite these guidelines, with studies showing 45-54% of elderly patients receiving at least one PIM. 4 Meloxicam specifically appears among the most frequently prescribed inappropriate medications in geriatric populations. 4
Safer Alternatives
When pain management is needed in older adults, clinicians should:
- Consider acetaminophen as first-line therapy for mild to moderate pain 1
- Use topical NSAIDs when appropriate for localized musculoskeletal pain 1
- Employ non-pharmacologic interventions including physical therapy 1
- If oral NSAIDs are absolutely necessary, use the lowest effective dose for the shortest duration possible with gastroprotection (proton-pump inhibitors or misoprostol) 1
Important Caveats
The Beers Criteria are designed as an educational tool and quality measure, not to be applied punitively. 1 However, the strong recommendation against meloxicam use in older adults reflects a clear unfavorable balance of benefits versus harms in this population. 1 The 2023 update of the Beers Criteria continues to maintain NSAIDs, including meloxicam, on the potentially inappropriate medication list. 5